Praxis Precision Medicines, Inc.
KCNT1 INHIBITORS AND METHODS OF USE
Last updated:
Abstract:
The present invention is directed to, in part, compounds and compositions useful for preventing and/or treating a neurological disease or disorder, a disease or condition relating to excessive neuronal excitability, and/or a gain-of-function mutation in a gene (e.g., KCNT1). Methods of treating a neurological disease or disorder, a disease or condition relating to excessive neuronal excitability, and/or a gain-of-function mutation in a gene such as KCNT1 are also provided herein.
Status:
Application
Type:
Utility
Filling date:
1 May 2020
Issue date:
18 Aug 2022